- Report
- January 2026
- 181 Pages
Global
From €3158EUR$3,545USD£2,732GBP
€3508EUR$3,939USD£3,036GBP
- Report
- August 2025
- 181 Pages
Global
From €3158EUR$3,545USD£2,732GBP
€3508EUR$3,939USD£3,036GBP
- Report
- May 2026
- 480 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 382 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- January 2026
- 185 Pages
Global
From €4008EUR$4,500USD£3,468GBP
- Report
- January 2026
- 181 Pages
Global
From €4008EUR$4,500USD£3,468GBP
- Report
- May 2026
- 210 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 383 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 396 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 566 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 273 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 697 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 253 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 329 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 471 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more